Deerfield Management’s Pfizer PFE Stock Holding History

Deerfield Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$73.2M	Hold	3,040,000	–	–	0.76%	37
2026 Q1	$85.4M	Buy	+3,040,000	New	+$80.9M	1.01%	32
2025 Q4	–	Sell	-3,303,790	Closed	-$84.2M	–	171
2025 Q3	$84.2M	Sell	3,303,790 -1,002,474	-23%	-$24.7M	1.29%	23
2025 Q2	$104M	Buy	4,306,264 +958,968	+29%	+$22.4M	1.89%	16
2025 Q1	$84.8M	Buy	+3,347,296	New	+$87.6M	1.67%	18
2016 Q2	–	Sell	-26,350	Closed	-$741K	–	113
2016 Q1	$741K	Buy	+26,350	New	+$753K	0.03%	99
2013 Q4	–	Sell	-1,902,470	Closed	-$51.8M	–	121
2013 Q3	$51.8M	Sell	1,902,470 -52,700	-3%	-$1.43M	2.41%	6
2013 Q2	$52M	Buy	+1,955,170	New	+$54M	2.45%	7

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deerfield Management's PFE Position: Q2 2026 in Review

Deerfield Management held its Pfizer (PFE) position steady in Q2 2026 at 3,040,000 shares worth $73.2M. The position accounts for 0.76% of the portfolio, ranked #37.

Deerfield Management first reported a position in PFE in Q2 2013 and has held it in 8 quarters since. The position peaked at $104M in Q2 2025. 2,826 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Deerfield Management held 3,040,000 shares of Pfizer worth $73.2M as of Q2 2026.
Deerfield Management left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.76% of Deerfield Management's portfolio in Q2 2026, its #37 holding.
Deerfield Management first reported a position in Pfizer in Q2 2013 and has held it in 8 quarters since.
Deerfield Management's Pfizer position peaked at $104M in Q2 2025.
2,826 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Deerfield Management's 13F filing for Q2 2026, filed 14 Aug 2026.